Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00575081 · ClinicalTrials.gov registry record

Physiological Brain Atlas Development

A clinical trial of Epilepsy and Parkinson's Disease, sponsored by Vanderbilt University Medical Center.

Recruiting
Registry status
5,000
Enrollment target
1
Study location

NCT00575081 is a study of Epilepsy and Parkinson's Disease that is actively recruiting participants, run by Vanderbilt University Medical Center. The registered enrollment target is 5,000 participants, above the 921-participant average among 160 other Epilepsy trials with a reported enrollment target (443% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00575081, a study of Epilepsy and Parkinson's Disease, is actively recruiting participants, sponsored by Vanderbilt University Medical Center.

RECRUITING
Registry status
5,000 participants
Enrollment target
1
Study location

Study Summary

The NIH grant has funded the development of a physiological brain atlas registry that will allow us to significantly improve the data collectioin and use of physiological data into a normalized brain volume. This initially was used to improve DBS implants for Parkinson's Disease, Dystonia, Essential Tremor, and OCD, but now includes data acquired during all stereotactic brain procedures.

Interventions

  • DEVICE Stereotactic brain procedures

Study Locations (1)

Tennessee

  • Vanderbilt Univeristy - Nashville

Trial Details

FieldValue
Enrollment Target 5,000 participants
Start Date 2006-08
Est. Completion 2026-08

What the Registry Record Tells You About NCT00575081

The ClinicalTrials.gov registry entry for NCT00575081 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 5,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 921-participant average among 160 other Epilepsy trials with a reported enrollment target (443% higher). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Epilepsy appearing as the primary indexed condition, and to 1 intervention - of which Stereotactic brain procedures is the first listed.

NCT00575081 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT00575081 about?

NCT00575081 is a clinical study titled "Physiological Brain Atlas Development". The NIH grant has funded the development of a physiological brain atlas registry that will allow us to significantly improve the data collectioin and use of physiological data into a normalized brain volume. This initially was used to improve DBS implants for Parkinson's Disease, Dystonia, Essential...

What is the current status of trial NCT00575081?

This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2006-08. Estimated completion is 2026-08.

What conditions does trial NCT00575081 study?

This clinical trial studies the following conditions: Epilepsy, Parkinson's Disease, Obsessive - Compulsive Disorder, Essential Tremor, Dystonia.

What interventions are being tested in trial NCT00575081?

The interventions under investigation include: Stereotactic brain procedures (DEVICE).

Who is sponsoring clinical trial NCT00575081?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00575081 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Epilepsy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.